Why Medical Device Manufacturers Must Look at the Bigger Picture When Implementing a GLS

What are the benefits of a GLS and why are MedTech companies considering it now?

Read More

Clinical Trials: Managing Labeling Approvals with Multi-Language and Multi-Region Regulations

Now more than ever, the clinical trials’ landscape touches more regions than ever before. As a result, new studies are grappling with the challenge of managing variable local language labeling requirements.  Read More

PRISYM ID announces six further projects go live as medical device and life science organizations prepare for the future

PRISYM ID has implemented a further six new regulated labeling software systems across the medical device and life sciences sectors.

Read More

COVID LEGACY: A New Era For Clinical Trials?

In the last fifteen months both individuals and organizations have had to change their behaviors. It’s typically meant more activity being done remotely, requiring greater agility and pace to deliver against changing demand, with technology often being deployed to overcome the unique challenges the pandemic has posed. Read More